News

10/02/2022

An agreement was signed with our Industrial partner for the development of our main “Skolkovo” project “A blood pressure monitor with the function of assessing the state of blood vessels”. It is planned to develop a software and metrological support of the tonometer, as well as the design of new results of intellectual property.

25/06/2021

Since June 25, 2021, ODS-MED LLC has been assigned the status of a Participant in the Project for the creation and maintenance of the Skolkovo Innovation Center for the Biomedical Technologies cluster. Participant number 1124010. Record number 1185477.

25/12/2020

An application has been submitted for the status of a Participant in the Project on the creation and maintenance of the Skolkovo Innovation Center for the Biomedical Technologies cluster.

21/09/2020

The project of the competition “Start” of the Foundation for Assistance to Small Innovative Enterprises (FASIE) has been successfully completed. A prototype of a combined tissue and cerebral oximeter has been created. The project is entering the stage of searching for industrial partners.

12/04/2020

In the quarantine mode, the company operates under an abbreviated program in a remote access mode.

02/12/2019

The first stage of the research under the agreement No. 3202C1/48653 with the Foundation for Assistance to Small Innovative Enterprises (FASIE) has been successfully completed.

02/09/2019

Agreement No. 3202GS1 / 48653 was signed with the Foundation for Assistance to Small Innovative Enterprises (FASIE) to provide a grant for research and development on the topic of design and creation a diagnostic devices line for noninvasive assessment of peripheral and cerebral hemodynamics parameters based on the block-modular concept of a multifunctional oximeter.

25/04/2019

The company entered into the first business agreement with a representative of the real sector of the economy for R&D on the topic of developing a professional version of the optical noninvasive tonometer for patients with diabetes.